In-situ microparticles for drug delivery

The objective of this project is to determine the effect of formulation parameters on the in vitro drug release of a hydrophilic model drug (metoclopramide hydrochloride) from ISM-systems. A solution of metoclopramide hydrochloride and poly(lactide-co-glycolide) – PDLLA or PDLG 5002 in N-methyl-2-py...

Full description

Saved in:
Bibliographic Details
Main Author: Lee, Tiffany Cai Feng.
Other Authors: Subramanian Venkatraman
Format: Final Year Project
Language:English
Published: 2010
Subjects:
Online Access:http://hdl.handle.net/10356/42397
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-42397
record_format dspace
spelling sg-ntu-dr.10356-423972023-03-04T15:34:47Z In-situ microparticles for drug delivery Lee, Tiffany Cai Feng. Subramanian Venkatraman School of Materials Science and Engineering DRNTU::Engineering The objective of this project is to determine the effect of formulation parameters on the in vitro drug release of a hydrophilic model drug (metoclopramide hydrochloride) from ISM-systems. A solution of metoclopramide hydrochloride and poly(lactide-co-glycolide) – PDLLA or PDLG 5002 in N-methyl-2-pyrrolideone (NMP) was emulsified into an external oil phase using an Ultra-Turrax homogenizer. After injection into a buffer medium, diffusion of NMP led to polymer precipitation and microparticles formation in situ. UV spectroscopy (UV), Scanning Electron Microscopy (SEM), Gel Permeation Chromatography (GPC) and pH test were performed to relate the drug release of ISM-systems to the surface properties, particle size and polymer degradation/erosion. ISM-systems prepared with 30% PDLLA (polymer/oil phase ratio of 1:1 and 5% drug loading) showed a high initial release of 86.3%. The initial release could be reduced by increasing the polymer concentration, decreasing polymer/oil phase, and drug loading. Under the same formulation conditions, ISM-systems prepared with PDLG 5002 had a much lower initial release (approximately 39.4%) compared to that from PDLLA. In addition, a second solvent – triacetin was added to both ISM-systems to aid in lowering the initial drug release. Since triacetin is partially soluble in water, it has lower affinity for water. This results in slower exchange rate between water and solvent, which was correlated to a slower and lower initial drug release. Hence, from this project, it could be noticed that varying formulation and processing parameters of ISM-systems could affect the initial release. Bachelor of Engineering (Materials Engineering) 2010-11-30T04:22:48Z 2010-11-30T04:22:48Z 2010 2010 Final Year Project (FYP) http://hdl.handle.net/10356/42397 en Nanyang Technological University 44 p. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic DRNTU::Engineering
spellingShingle DRNTU::Engineering
Lee, Tiffany Cai Feng.
In-situ microparticles for drug delivery
description The objective of this project is to determine the effect of formulation parameters on the in vitro drug release of a hydrophilic model drug (metoclopramide hydrochloride) from ISM-systems. A solution of metoclopramide hydrochloride and poly(lactide-co-glycolide) – PDLLA or PDLG 5002 in N-methyl-2-pyrrolideone (NMP) was emulsified into an external oil phase using an Ultra-Turrax homogenizer. After injection into a buffer medium, diffusion of NMP led to polymer precipitation and microparticles formation in situ. UV spectroscopy (UV), Scanning Electron Microscopy (SEM), Gel Permeation Chromatography (GPC) and pH test were performed to relate the drug release of ISM-systems to the surface properties, particle size and polymer degradation/erosion. ISM-systems prepared with 30% PDLLA (polymer/oil phase ratio of 1:1 and 5% drug loading) showed a high initial release of 86.3%. The initial release could be reduced by increasing the polymer concentration, decreasing polymer/oil phase, and drug loading. Under the same formulation conditions, ISM-systems prepared with PDLG 5002 had a much lower initial release (approximately 39.4%) compared to that from PDLLA. In addition, a second solvent – triacetin was added to both ISM-systems to aid in lowering the initial drug release. Since triacetin is partially soluble in water, it has lower affinity for water. This results in slower exchange rate between water and solvent, which was correlated to a slower and lower initial drug release. Hence, from this project, it could be noticed that varying formulation and processing parameters of ISM-systems could affect the initial release.
author2 Subramanian Venkatraman
author_facet Subramanian Venkatraman
Lee, Tiffany Cai Feng.
format Final Year Project
author Lee, Tiffany Cai Feng.
author_sort Lee, Tiffany Cai Feng.
title In-situ microparticles for drug delivery
title_short In-situ microparticles for drug delivery
title_full In-situ microparticles for drug delivery
title_fullStr In-situ microparticles for drug delivery
title_full_unstemmed In-situ microparticles for drug delivery
title_sort in-situ microparticles for drug delivery
publishDate 2010
url http://hdl.handle.net/10356/42397
_version_ 1759857557217738752